Table 1.
Patient baseline characteristics and treatments.
| Baseline characteristic | RT + TMZ + TTFields |
|---|---|
| Age (years) | |
| Mean (SD) | 59.9 (8.25) |
| Median (range) | 60.2 (42–72) |
| Karnofsky performance score | |
| Median (range) | 90.0 (80–100) |
| Sex, n (%) | |
| Male | 8 (80.0) |
| Extent of resection, n (%) | |
| Biopsy | 5 (50.0) |
| Tumor resection | 5 (50.0) |
| Number of TTFields cycles | |
| Median (range) | 9.0 (1–16) |
| Follow-up duration | |
| Median (range) | 8.6 (2–15) |
| Compliance in the RT period (%) | |
| Mean (SD) | 79.3 (8.36) |
| Compliance in the first 3 months (%) | |
| Mean (SD) | 77.0 (10.56) |
RT, radiation therapy; SD, standard deviation; TMZ, temozolomide; TTFields, Tumor Treating Fields.